Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-22

Clinical Trial Update: Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating reformulated Levulan Kerastick Plus PDT for actinic keratosis on the upper extremities is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levulan Kerastick Plus PDT (5-aminolevulinic acid–based photodynamic therapy)

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Actinic Keratosis | Phase 3 | Status: RECRUITING